Psychological Burden Associated With Lung Cancer Screening: A Systematic Review

Clinical Lung Cancer

Volumn 17, Issue 5, 2016, Pages 315-324

  Wu, Geena X ^a   Raz, Dan J ^a   Brown, Laura ^a   Sun, Virginia ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Anxiety; Health related quality of life; Low dose computed tomography; Psychological distress; Shared decision making

Indexed keywords

ADVERSE OUTCOME; CANCER SCREENING; CINAHL; COHORT ANALYSIS; FALSE POSITIVE RESULT; FOLLOW UP; HUMAN; LANGUAGE; LUNG CANCER; MEDICAL LITERATURE; MEDLINE; MENTAL STRESS; PSYCINFO; PUBLICATION; QUALITATIVE RESEARCH; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCOPUS; STUDY DESIGN; SYSTEMATIC REVIEW; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; LUNG TUMOR; MASS SCREENING; PROCEDURES; PSYCHOLOGY; TIME FACTOR; X-RAY COMPUTED TOMOGRAPHY;

EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; HUMANS; LUNG NEOPLASMS; MASS SCREENING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84964670034     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2016.03.007     Document Type: Review

References (33)

1. 1 Centers for Disease Control and Prevention. CDC WONDER On-line Database. Vol Series 20: National Center for Health Statistics, No. 2P. 2013. Available at: http://wonder.cdc.gov/. Accessed: April 14, 2016.
2. 2 Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics. CA Cancer J Clin 66 (2016), 7–30.
3. 3 National Cancer Institute. Surveillance, Epidemiology, and End Results Program. SEER Cancer Statistics Review, 1975-2011. Available at: http://seer.cancer.gov/csr/1975_2011. Accessed: October 1, 2015.
4. 4 Henschke, C.I., International Early Lung Cancer Action Program I. Survival of patients with clinical stage I lung cancer diagnosed by computed tomography screening for lung cancer. Clin Cancer Res 13 (2007), 4949–4950.
5. 5 National Lung Screening Trial Research Team, Aberle, D.R., Adams, A.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365 (2011), 395–409.
6. 6 Moyer, V.A., U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160 (2014), 330–338.
7. 7 Wender, R., Fontham, E.T., Barrera, E. Jr., et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 63 (2013), 107–117.
8. 8 Jensen, T., Chin, J., Ashby, L., Hermansen, J., Hutter, J., Final National Coverage Determination on Screening for Lung Cancer with Low Dose Computed Tomography (LDCT). 2015, The Centers for Medicare & Medicaid Services (CMS) CAG-00439N. Available at: https://www.cms.gov Accessed: April 14, 2016.
9. 9 Bach, P.B., Mirkin, J.N., Oliver, T.K., et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307 (2012), 2418–2429.
10. 10 DeFrank, J.T., Barclay, C., Sheridan, S., et al. The psychological harms of screening: the evidence we have versus the evidence we need. J Gen Intern Med 30 (2015), 242–248.
11. 11 Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med, 6, 2009, e1000097.
12. 12 van Iersel, C.A., de Koning, H.J., Draisma, G., et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 120 (2007), 868–874.
13. 13 National Lung Screening Trial Research Team, Aberle, D.R., Adams, A.M., et al. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst 102 (2010), 1771–1779.
14. 14 Pedersen, J.H., Ashraf, H., Dirksen, A., et al. The Danish randomized lung cancer CT screening trial–overall design and results of the prevalence round. J Thorac Oncol 4 (2009), 608–614.
15. 15 Byrne, M.M., Weissfeld, J., Roberts, M.S., Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med Decis Making 28 (2008), 917–925.
16. 16 Vierikko, T., Kivisto, S., Jarvenpaa, R., et al. Psychological impact of computed tomography screening for lung cancer and occupational pulmonary disease among asbestos-exposed workers. Eur J Cancer Prev 18 (2009), 203–206.
17. 17 Sinicrope, P.S., Rabe, K.G., Brockman, T.A., et al. Perceptions of lung cancer risk and beliefs in screening accuracy of spiral computed tomography among high-risk lung cancer family members. Acad Radiol 17 (2010), 1012–1025.
18. 18 Gareen, I.F., Duan, F., Greco, E.M., et al. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer 120 (2014), 3401–3409.
19. 19 Aggestrup, L.M., Hestbech, M.S., Siersma, V., Pedersen, J.H., Brodersen, J., Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial. BMJ Open, 2, 2012, e000663.
20. 20 van den Bergh, K.A., Essink-Bot, M.L., Bunge, E.M., et al. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). Cancer 113 (2008), 396–404.
21. 21 van den Bergh, K.A., Essink-Bot, M.L., Borsboom, G.J., et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer 102 (2010), 27–34.
22. 22 van den Bergh, K.A., Essink-Bot, M.L., van Klaveren, R.J., de Koning, H.J., Informed decision-making does not affect health-related quality of life in lung cancer screening (NELSON trial). Eur J Cancer 46 (2010), 3300–3306.
23. 23 Kaerlev, L., Iachina, M., Pedersen, J.H., Green, A., Norgard, B.M., CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication. BMC Cancer, 12, 2012, 188.
24. 24 Bunge, E.M., van den Bergh, K.A., Essink-Bot, M.L., van Klaveren, R.J., de Koning, H.J., High affective risk perception is associated with more lung cancer-specific distress in CT screening for lung cancer. Lung Cancer 62 (2008), 385–390.
25. 25 van den Bergh, K.A., Essink-Bot, M.L., Borsboom, G.J., Scholten, E.T., van Klaveren, R.J., de Koning, H.J., Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur J Respir J 38 (2011), 154–161.
26. 26 Rasmussen, J.F., Siersma, V., Pedersen, J.H., Brodersen, J., Psychosocial consequences in the Danish randomised controlled lung cancer screening trial (DLCST). Lung Cancer 87 (2015), 65–72.
27. 27 Hestbech, M.S., Siersma, V., Dirksen, A., Pedersen, J.H., Brodersen, J., Participation bias in a randomised trial of screening for lung cancer. Lung Cancer 73 (2011), 325–331.
28. 28 Brodersen, J., Thorsen, H., Kreiner, S., Consequences of screening in lung cancer: development and dimensionality of a questionnaire. Value Health 13 (2010), 601–612.
29. 29 Brett, J., Bankhead, C., Henderson, B., Watson, E., Austoker, J., The psychological impact of mammographic screening. A systematic review. Psychooncology 14 (2005), 917–938.
30. 30 Brodersen, J., Siersma, V.D., Long-term psychosocial consequences of false-positive screening mammography. Ann Fam Med 11 (2013), 106–115.
31. 31 Harris, R.P., Sheridan, S.L., Lewis, C.L., et al. The harms of screening: a proposed taxonomy and application to lung cancer screening. JAMA Intern Med 174 (2014), 281–285.
32. 32 Harris, R.P., The psychological effects of lung cancer screening on heavy smokers: another reason for concern. JAMA Intern Med 175 (2015), 1537–1538.
33. 33 International Patient Decision Aid Standards (IPDAS) Collaboration. What are patient decision aids? Available at: http://ipdas.ohri.ca/what.html. Accessed: November 4, 2015.